Total Funding
76
57
Total FundingSeries B raised
Growth Score
-7 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2699265
Pieris is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and so on.
Kristian Jensen: COO- Claus Schalper: CEO/CFO and Co-founder
About the Company
Pieris Pharmaceuticals is a clinical-stage biotechnology company that develops drugs to fight cancer, severe asthma, anemia, and other medical conditions with unmet medical needs. The company applies its proprietary Anticalin® technology to the drug development processes.
Pieris Pharmaceuticals was founded in 2001 and is based in Freising,
Bayern.
